Thermal Decomposition Kinetics of Some Di- and Triorganotin（IV） Carboxylates Derived from para-Nitrophenylethanoic Acid

Thermogravimetric （TG） investigations of organotin（IV） carboxylates with the general formula RmSnL4-m （where R=CH3, C2H5, n-C4H9, C6H5, cyclo-C6H11, n-C8H17, m=2, 3, and L=para-nitrophenylethanoate anion） have been performed. Derivative thermogravimetry （DTG） and differential thermal analysis （DTA） techniques, Horowitz-Metzger method and the fundamental thermodynamic relations are used to evaluate the thermokinetic pa- rameters of each thermal degradation pattern. Results reveal that the thermal stability is functional to Sn--C and Sn--O bonds. In the case of R2SnL2, activation energy, reaction order and pre-exponential factor associated with the bulk degradation processes increase as the alkane chain length increases. Hence, Oct2SnL2 is thermally more stable than Bu2SnL2, which in turn is more resistant to thermal dissociation than Et2SnL2. The same phenomenon is not observed for R3SnL compounds because their degradation is highly irregular. Furthermore, R2SnL2 has larger values of kinetic parameters than those of corresponding triorganotin（IV） para-nitrophenylethanotes. Thermodynamic parameters of these compounds also reinforce the above facts.

负压封闭引流联合保留臀上动脉浅支的臀大肌肌皮瓣修复骶尾部IV期压疮的临床效果

目的:探讨负压封闭引流联合保留臀上动脉浅支的臀大肌旋转肌皮瓣修复骶尾部压疮的临床效果。方法:选取2019年6月—2023年10月温州医科大学附属第一医院收治的12例骶尾部压疮患者,其中男7例,女5例,年龄31~86岁。入院后I期予行负压封闭引流术,4~7 d后行保留臀上动脉浅支的臀大肌肌皮瓣修复创面。观察术后皮瓣成活情况、并发症发生情况,随访观察皮瓣外形、压疮复发情况。结果:本组12例患者,均因长期卧床致骶尾部受压出现IV期压疮,压疮病因:截瘫患者5例,各种原因所致的长期卧床患者7例,其中脑梗死后遗症患者2例,帕金森病患者3例,老年痴呆症患者1例,股骨颈骨折患者1例。病程2周至8年,清创后创面面积为5.0 cm×5.0 cm~10.0 cm×12.0 cm。12例患者术后皮瓣均完全成活,无皮瓣坏死、静脉淤血、创缘开裂等发生。术后随访2~6个月,皮瓣外形较佳、骶尾部软组织饱满、压疮无复发。结论:保留臀上动脉浅支的臀大肌旋转肌皮瓣血运可靠,设计、操作简单,皮瓣可修复面积大,切取不需要离断臀上动脉浅支,供瓣区一般能直接缝合,修复骶尾部压疮效果较佳。

Investigation on the Antitumor Activity of Organotin Compound

Changes in the surface structure of cell membrane and the contents of membrane pro- teins and nuclear DNA of human gastric cancer (BGC-823) cells treated with organotin compound (Et_2SnCl_2phen) were studied with a scanning electron microscope (SEM),a scanning tunneling,micro- scope (STM),and a cytofluorophotometer.It was found that Et_2SnCl_2Phen not only inhibited the cell growth but also remarkably changed the surface structure of the membrane of cancer cells.The surface of Et_2SnCl_2phen treated cancer cells was relatively smooth and showed fewer microvilli under SEM. STM images showed an uneven and loose distribution of the surface of the cell.In comparison with the untreated cancer cells,there was an evident decrease in the content of membrane proteins and nuclear DNA in Et_2SnCl_2phen treated cells.

Synthesis, Characterization and Biological Activity of Diorganotin（IV） Complexes of N-（3,5-Dibromosalicylidene）-α-amino Acid

The diorganotin（Ⅳ） complexes of N-（3,5-dibromosalicylidene）-α-amino acid, R2Sn（2-O-3,5-Br2C6H2CH= NCHRCOO）（where R=H, Me, i-Pr, Bz; R＇=n-Bu, Cy）, were synthesized by the reactions of diorganotin dichlorides with in situ formed potassium salt of N-（3,5-dibromosalicylidene）-α-amino acid and characterized by elemental analysis, IR and NMR （^1H, ^13C and ^119Sn） spectra. The crystal structures of n-Bu2Sn（2-O-3,5-Br2C6H2CH= NCHRCOO）（R=i-Pr, Bz） and Cy2Sn（2-O-3,5-Br2C6H2CH=NCHRCOO）（R=Me, Bz） were determined by X-ray single crystal diffraction and showed that the tin atoms are in a distorted trigonal bipyramidal geometry to form five- and six-membered chelate rings with the tridentate ligand. Bioassay results indicated that the compounds possess better in vitro antitumour activity against three human tumour cell lines, HeLa, CoLo205 and MCF-7, than cis-platin and moderate anti-bacterial activity against two bacteria, E. coli and S. aureus.

Synthesis,Structure and Biological Activities of a Novel Anionic Organotin(Ⅳ)Complex{[(pClC6H4CH2)Sn(H2O)(Cl)2OCOCH(O)CH(O)CO2Sn(H2O)(Cl)2(p-ClC6H4CH2)]·2(HNEt3)}

A novel anionic organotin(Ⅳ) complex {[(pClCHCH)Sn(HO)(Cl)OCOCH(O)CH(O)COSn(HO)(Cl)(p-ClCHCH)]·2(HNEt)}(1) was synthesized by the reaction of di(p-chlorobenzy)tin dichloride with the D-tartaric acid in 2:1 molar in the presence of an organic base triethylamine. The structure was characterized by elemental analysis, IR, TG, XRD and single-crystal X-ray diffraction. It crystallizes in triclinic, P1 space group, with a = 0.7067(1), b = 1.9762(3), c = 2.2383(3) nm, α = 91.544(2)°, β = 90.075(2)°, γ = 90.110(2)°, V = 3.1247(7) nm~3, Z = 3, Dc = 1.621 g/cm~3, m(Mo Kα) = 16.29 cm–1, F(000) = 1530, R = 0.0394, wR = 0.1092,(Δρ)max = 1224 and(Δρ)min = –840 e/nm~3. The stabilities, orbital energies and composition characteristics of some frontier molecular orbitals of 1 have been carefully investigated with quantum chemistry calculation. In addition, the in vitro antitumor activity suggested that 1 had stronger inhibitory activity on H460, MCF7 than on A549.

Synthesis, Structural Investigations and Biological Screening of Diorganotin(IV) Complexes Derived from 5,5-Diethyl Sodium Barbital

Some biologically important tin（Ⅳ） complexes derived from 5,5-diethyl sodium barbital have been synthesized and characterized through various analytical and spectroscopic techniques such as IR, ^1H-, ^13C-NMR and ^119mSn mossbauer. On the basis of these spectroscopic techniques, octahedral geometry has been assigned to all the novel compounds. These complexes, soluble in DMSO and DMF, were screened against a wide range of microorganisms. The results proved that the diphenyltin（Ⅳ） and dibutyltin（Ⅳ） complexes exhibit excellent activity against all types of microorganisms, while the rest of the compounds show significant activity that can be used during the biological study.

IV型车载储氢瓶聚合物内衬材料的氢气渗透性分析

详细总结论述了气体在高分子聚合物材料中的渗透机理,并简要介绍了有关IV型储氢瓶聚合物内衬氢气渗透性的测试方法以及国内外测试标准。基于此,进一步探讨了测试温度、测试压力以及聚合物材料性能对IV型储氢瓶内衬材料氢气渗透性的影响,并展望了未来的发展方向。

基于MIMIC-IV构建及评估脓毒症患者近期和远期死亡风险预测模型

目的:鉴于脓毒症的高发病率和高病死率,早期识别高风险患者并及时干预至关重要,而现有死亡风险预测模型在操作、适用性和预测长期预后等方面均存在不足。本研究旨在探讨脓毒症患者死亡的危险因素,构建近期和远期死亡风险预测模型。方法:从美国重症监护医学信息数据库IV(Medical Information Mart for Intensive Care-IV,MIMIC-IV)中选取符合脓毒症3.0诊断标准的人群,按7?3的比例随机分为建模组和验证组,分析患者的基线资料。采用单因素Cox回归分析和全子集回归确定脓毒症患者死亡的危险因素并筛选出构建预测模型的变量。分别用时间依赖性曲线下面积(area under the curve,AUC)、校准曲线和决策曲线评估模型的区分度、校准度和临床实用性。结果:共纳入14240例脓毒症患者,28 d和1年病死率分别为21.45%(3054例)和36.50%(5198例)。高龄、女性、高感染相关器官衰竭评分(sepsis-related organ failure assessment,SOFA)、高简明急性生理学评分(simplified acute physiology score II,SAPS II)、心率快、呼吸频率快、脓毒症休克、充血性心力衰竭、慢性阻塞性肺疾病、肝脏疾病、肾脏疾病、糖尿病、恶性肿瘤、高白细胞计数(white blood cell count,WBC)、长凝血酶原时间(prothrombin time,PT)、高血肌酐(serum creatinine,SCr)水平均为脓毒症死亡的危险因素(均P<0.05)。由PT、呼吸频率、体温、合并恶性肿瘤、合并肝脏疾病、脓毒症休克、SAPS II及年龄8个变量构建的模型,其28 d和1年生存的AUC分别为0.717(95%CI 0.710~0.724)和0.716(95%CI 0.707~0.725)。校准曲线和决策曲线表明该模型具有良好的校准度及较好的临床应用价值。结论:基于MIMIC-IV建立的脓毒症患者近期和远期死亡风险预测模型有较好的识别能力,对患者预后风险评估及干预治疗具有一定的临床参考意义。

基于IVE模型重型柴油车尾气排放时空特征分析

该研究基于国际机动车排放(IVE)模型结合GPS轨迹点密度和道路长度的方法,建立了昆明市主城区重型柴油车大气污染物和温室气体的高分辨率网格化排放清单,量化了重型柴油车的行驶特征,确定了车辆的VSP bin分布特征、环境变量和车辆技术特征,改进了污染物空间分配方法。结果表明,昆明市主城区的CO_(2)、NOx和PM日排放总量分别为373.481、2.43和0.193 t。驾驶模式工况主要向VSP bin12趋近,其后逐渐降低;污染物的排放因子随车速变化而有规律的变化。从时间分布来看,污染物的小时排放模式均呈现出双峰趋势,表明交通拥堵和通勤高峰时段是污染物排放的主要时段;将轨迹点密度和网格道路长度作为污染物空间分配的权重因子,能够更真实地反映污染物排放强度的分布模式。

Synthesis, spectral characterization and biological activities of Organotin(IV) complexes with <i>ortho</i>-vanillin-2-hydrazinopyridine (VHP)

Five new organotin(IV) complexes of ortho-vanillin-2-hydrazinopyridine hydrazone with formula [RnSnCl4–n(VHP)] [R = Me2, n = 2 (2);R = Ph2, n = 2 (3);R= nBu2, n = 2 (4);R = nBu, n = 2 (5) and R = 1, n = 0 (6)] have been synthesized by direct reaction of ortho-vanillin-2-hydrazinopyridine hydrazone [(VHP), (1)], base and organotin(IV) chloride(s) in absolute methanol. The hydrazone ligand [(VHP), (1)] and its organotin(IV) complexes (2-6) have been characterized by UV-Visible, FT-IR and 1H NMR spectral studies. Spectroscopic data suggested that in the complexes (2-4), the ligand (1) acted as a neutral bidentate ligand and is coordinated to the tin(IV) atom via the azomethine nitrogen and pyridyl nitrogen atoms, whereas the ligand (1) acted as a uninegative tridentate ligand and coordinated to the tin(IV) atom through phenolic-O, azomethine-N and pyridyl-N atoms in complexes (5-6). The toxicity of the ligand (1) and its organotin (IV) complexes (2-6) were determined against Artemia salina. Organotin(IV) complexes showed moderate activity against Artemia salina. The ligand (1) and its organotin(IV) complexes (2-6) were also tested against four types of bacteria namely Bacillus cereus, Staphylococcus aureus, Escherichia coli and Enterobacter aerogenes. All organotin(IV) complexes and the free ligand (1) showed better antibacterial activities against bacteria. Among the organotin(IV) complexes (2-6), diphenyltin(IV) complex (3) showed higher activity against the four types of bacteria.

Formation,Structure and In Vitro Antitumour Activity of a Novel Binuclear Organotin Complex

A 1：1 reaction of triphenyltin chloride with potassium N-[（3,5-dibromo-2-hydroxylphenyl）methylene]valinate in benzene led to the formation of a novel mixed organotin dinuclear complex, （HL）SnPh3oPh2SnL [L=2-O-3,5-Br2C6H3CH=NCH（i-Pr）COO], by means of a facile phenyl-tin bond cleavage process. In the complex, there are two distinct types of carboxylate moieties and a trans-O2SnC2N and a trans-O2SnC3 in distorted trigonal bipyramidal geometries were bridged by a carboxylate group. In vitro antitumor activity of the complex against three human tumour cell lines （HeLa, CoLo205 and MCF-7） was found to be much higher than cis-platin used in clinic.

Preparation and Tribological Performance of Novel Organotin Compound as Lubricant Additive

Oil-soluble stannous naphthenate (SN) is synthesized by using naphthenatic acid and SnO. And its molecular structure is confirmed by IR and multielement oil analyzer (MOA). The tribological performances of the organotin as lubricant additive are evaluated with a four-ball friction and wear tester. These experiments indicate that the wear scar diameter (WSD) and friction coefficient are diminished while the load-carrying capability increased by comparison with that of base oil. The elemental composition of the boundary lubricating film is examined by means of Auger electron spectroscopy (AES). Synergistic effect is found in the load-carrying capability of the complex of SN and sulfured olefin. The analytical results of AES indicate that the good performance of stannous naphthenate is attributed to the formation of a boundary lubricating film containing Sn on the rubbed surface.

基于STM32F373的光伏组件IV特性测试系统

为准确方便测量光伏组件的IV特性曲线,设计一款基于STM32F373的光伏组件IV特性测试系统,可测量开路电压、短路电流、IV曲线、PV曲线等。该系统由电流控制单元、信号采集单元、软件处理单元、通信单元、上位机显示单元等组成,采用电子负载电路,以STM32F373单片机DAC输出来调节恒流的电流,同时采集光伏电池的输出电压,对采集到的数据进行卡尔曼滤波和曲线拟合,将电压、电流、功率生成IV、PV曲线显示在TFT彩屏上。该系统还可将数据远程传输到PC端进行数据分析与曲线观察。结果表明,该系统采集曲线准确且速度快,性能良好,采集一次IV曲线的时间仅需1 s,测量的电压电流误差小于1%。该系统体积小便于携带且内部带有锂电池,可充电,可在室外使用。

珍珠蚌肉二肽基肽酶-IV抑制肽的制备与分离

目的:以珍珠蚌肉为原料制备对二肽基肽酶(dipeptidyl peptidase,DPP)-IV具有抑制作用的生物活性肽。方法:利用两步酶解法并优化珍珠蚌肉酶解条件,筛选体外DPP-IV抑制活性较高组分进行超滤膜浓缩,Superdex^(TM) peptide 10/300 GL凝胶柱层析与反相高效液相色谱(reverse phase-high performance liquid chromatography,RP-HPLC)技术分离纯化出酶解液中的DPP-IV抑制肽,最终通过液相色谱-串联质谱鉴定其氨基酸序列。结果:中性蛋白酶与碱性蛋白酶对珍珠蚌肉均有良好降解效果,经3 kDa超滤膜浓缩后,酶解产物的DPP-IV抑制率可达67.4%。通过凝胶过滤柱和RP-HPLC进一步分离纯化出6个活性较高的肽段,序列分别为FNAPAM、FIPNY、IYNPPTPF、LAMPYP、FFVVMP和LAGMP。进一步,以分子对接的方式分析6个肽段与DPP-IV的相互作用关系。结论:本研究利用珍珠蚌肉制备DPP-IV抑制肽,可为以水产加工副产物为原料制备功能性食品提供理论参考。

参苓白术散联合桂枝茯苓丸、达格列净治疗2型糖尿病肾病IV期的蛋白尿的随机对照研究

目的:观察参苓白术散联合桂枝茯苓丸、达格列净治疗2型糖尿病肾病IV期患者蛋白尿的临床疗效。方法:收集于2021年9月~2022年9月潍坊市益都中心医院就诊的诊断为2型糖尿病肾病IV期患者60例。采用随机、对照的临床研究设计分为治疗组和对照组,观察患者症状评分、实验室指标、疾病疗效等指标变化。结果:本研究最终纳入统计分析的治疗组29例、对照组28例。治疗后,治疗组的中医证候、蛋白尿、肾小球滤过率(eGFR)、糖化血红蛋白(HbA1c)、D-二聚体、尿NGAL、低密度脂蛋白疗效优于对照组(P 0.05)。对照组经治后,尿NGAL较治疗前明显下降(P < 0.05),其余指标与治疗前均无差异(P < 0.05)。两组均未见不良反应。结论:参苓白术散联合桂枝茯苓丸、达格列净治疗可减轻DKD IV期患者临床症状,降低蛋白尿、NGAL、糖化血红蛋白、D-二聚体、低密度脂蛋白,保护肾小管及肾小球、改善机体高凝状态及血糖,延缓肾功能下降,提高临床疗效。

溶解素E1、可诱导共刺激分子、载脂蛋白A-IV在甲状腺功能减退症患者血清中的表达及相关性

目的探究甲状腺功能减退症(甲减)患者血清中溶解素E1(RvE1)、可诱导共刺激分子(ICOS)、载脂蛋白A-IV(Apo-AIV)表达水平,并分析其与疾病的相关性。方法选择2023年5月-2024年5月本院收治的234例甲减患者作为甲减组,另选同期240名甲状腺功能正常体检者作为对照组。依据垂体促甲状腺激素(TSH)及游离甲状腺素(FT4)水平将甲减组分为亚临床甲减组(103例)及临床甲减组(131例)。采用酶联免疫吸附法(ELISA)检测血清RvE1、ICOS、Apo-AIV水平,比较不同类型甲减患者甲状腺激素及血清RvE1、ICOS、Apo-AIV水平,采用Pearson法相关性分析血清RvE1、ICOS、Apo-AIV水平与甲状腺激素水平的相关性,采用多因素Logistic回归分析甲减发生的影响因素,采用受试者工作特征(ROC)曲线分析血清RvE1、ICOS、Apo-AIV水平对甲减的诊断价值。结果甲减组血清RvE1水平及游离三碘甲状腺原氨酸(FT3)、FT4水平低于对照组,血清ICOS、Apo-AIV水平及TSH水平高于对照组(P<0.05);亚临床甲减组患者血清RvE1水平及FT3、FT4水平高于临床甲减组,血清ICOS、Apo-AIV水平及TSH水平低于临床甲减组(P<0.05);血清RvE1水平与FT3、FT4水平正相关,与TSH水平负相关,血清ICOS、Apo-AIV水平与FT3、FT4水平负相关,与TSH水平正相关(P<0.05);血清RvE1(95%CI=0.464~0.692)、ICOS(95%CI=2.772~35.012)、Apo-AIV(95%CI=2.977~13.154)水平及FT3(95%CI=0.623~0.966)、FT4(95%CI=0.448~0.921)、TSH(95%CI=1.827~14.701)水平是甲减发生的影响因素(P<0.05);血清RvE1、ICOS、Apo-AIV水平联合诊断甲减发生的曲线下面积(AUC)高于血清RvE1水平单独诊断的AUC(Z=2.601,P=0.009),高于血清ICOS水平单独诊断的AUC(Z=7.638,P<0.05),高于血清Apo-AIV水平单独诊断的AUC(Z=5.391,P<0.05)。结论甲减患者血清RvE1水平降低,血清ICOS、Apo-AIV水平升高,与甲状腺激素水平相关,联合诊断甲减的价值较高。

18例不可切除IV期胸腺鳞癌的临床特征及预后分析

目的:探讨不可切除IV期胸腺鳞癌的临床特征、治疗方式和预后。方法:收集2018年1月1日至2022年12月31日期间就诊于青岛大学附属医院的18例不可切除IV期胸腺鳞癌患者的临床资料和治疗资料,并随访至2024年2月29日。结果:18例患者中男性12例,女性6例,中位发病年龄60岁;TNM分期IVA期9例,IVB期9例;单纯化疗8例,单纯放疗1例,序贯放化疗4例,同步放化疗2例,化疗联合免疫疗法3例。18例患者总进展率66.7%,中位PFS 27 (19~36)个月。IVA期和IVB期进展率分别为33.3%和100.0% (p = 0.009),中位PFS分别为50 (21~79)和21 (5~37)个月(p = 0.008)。单纯化疗,放化疗和化疗联合免疫疗法进展率分别为75.0%,66.7%,和33.3% (p = 0.793),中位PFS分别为24 (16~32),50 (27~73),和10 (4~16)个月(p = 0.057)。结论:不可切除IV期胸腺鳞癌主要采用以化疗为主的综合治疗,总体预后差,IVA期较IVB期好,化疗联合放疗或免疫疗法较单纯化疗好,建议对非广泛转移阶段的患者行精准治疗。

Anti-inflammatory and DNA Repair Effects of Astragaloside IV on PC12 Cells Damaged by Lipopolysaccharide

Objective This study aimed to establish a neural cell injury model in vitro by stimulating PC12 cells with lipopolysaccharide(LPS)and to examine the effects of astragaloside IV on key targets using high-throughput sequence technology and bioinformatics analyses.Methods PC12 cells in the logarithmic growth phase were treated with LPS at final concentrations of 0.25,0.5,0.75,1,and 1.25 mg/mL for 24 h.Cell morphology was evaluated,and cell survival rates were calculated.A neurocyte inflammatory model was established with LPS treatment,which reached a 50%cell survival rate.PC12 cells were treated with 0.01,0.1,1,10,or 100µmol/L astragaloside IV for 24 h.The concentration of astragaloside IV that did not affect the cell survival rate was selected as the treatment group for subsequent experiments.NOS activity was detected by colorimetry;the expression levels of ERCC2,XRCC4,XRCC2,TNF-α,IL-1β,TLR4,NOS and COX-2 mRNA and protein were detected by RT-qPCR and Western blotting.The differentially expressed genes(DEGs)between the groups were screened using a second-generation sequence(fold change>2,P<0.05)with the following KEGG enrichment analysis,RT-qPCR and Western blotting were used to detect the mRNA and protein expression of DEGs related to the IL-17 pathway in different groups of PC12 cells.Results The viability of PC12 cells was not altered by treatment with 0.01,0.1,or 1µmol/L astragaloside IV for 24 h(P>0.05).However,after treatment with 0.5,0.75,1,or 1.25 mg/mL LPS for 24 h,the viability steadily decreased(P<0.01).The mRNA and protein expression levels of ERCC2,XRCC4,XRCC2,TNF-α,IL-1β,TLR4,NOS,and COX-2 were significantly increased after PC12 cells were treated with 1 mg/mL LPS for 24 h(P<0.01);however,these changes were reversed when PC12 cells were pretreated with 0.01,0.1,or 1µmol/L astragaloside IV in PC12 cells and then treated with 1 mg/mL LPS for 24 h(P<0.05).Second-generation sequencing revealed that 1026 genes were upregulated,while 1287 genes were downregulated.The DEGs were associated with autophagy,TNF-α,interleukin-17,MAPK,P53,Toll-like receptor,and NOD-like receptor signaling pathways.Furthermore,PC12 cells treated with a 1 mg/mL LPS for 24 h exhibited increased mRNA and protein expression of CCL2,CCL11,CCL7,MMP3,and MMP10,which are associated with the IL-17 pathway.RT-qPCR and Western blotting analyses confirmed that the DEGs listed above corresponded to the sequence assay results.Conclusion LPS can damage PC12 cells and cause inflammatory reactions in nerve cells and DNA damage.astragaloside IV plays an anti-inflammatory and DNA damage protective role and inhibits the IL-17 signaling pathway to exert a neuroprotective effect in vitro.

基于IOE-IV耦合模型的地质灾害易发性评价——以陕西省城固县为例

地质灾害易发性评价是地质灾害排查、风险性调查评价及预警预报工作的基础,其成果可以作为建设工程是否进行地质灾害危险性评估工作的依据。因此,进行区域地质灾害易发性评价研究显得尤为重要。本文以城固县为研究区,以气象水文类、地形地貌类、基础地质类、植被覆盖类共4类12种诱发因素为评价指标。分别采用K-means算法、FCM算法、层次聚类算法、DBSCAN密度算法对区内126处地质灾害样本数据进行分析提纯,剔除13处样本噪声点。利用提纯后的113处样本点建立IOE-IV耦合模型,并对城固县地质灾害易发性进行分区评价,评价结果表明:(1)地质灾害极高—高易发区、中易发区、极低—低易发区的占比分别为92.04%、4.42%与3.54%,预测结果较合理准确;(2)地质灾害发育主要受高程、水系的控制,在高程412~500 m、距水系小于500 m范围内主要为极高—高易发区,地质灾害呈线状发育。研究成果可以为地质灾害易发性评价样本优化、模型选择提供一定的理论依据。

智能IV诊断在分析光伏低效子阵中的应用

由于光伏子阵的非线性行为和其对运行环境的依赖性,传统的保护装置可能无法诊断光伏系统低效子阵问题。为此,业内进行了大量研究来克服这一问题的出现。然而,大多数方法不仅耗时较久,还存在较大的电量损失。同时,由于需要大量数据集,还存在数据过度拟合问题,导致准确率有所欠缺。在本研究中,通过应用华为AI BOOST智能IV诊断3.0,无论是实验评估还是实际应用,相比传统的诊断方法,均取得了较为明显的效果。